Philip Okala Appointed to Colfax Board of Directors
February 22 2021 - 4:45PM
Colfax Corporation (NYSE: CFX), a leading diversified technology
company, today announced that it has appointed Philip Okala, Chief
Operating Officer of the University of Pennsylvania Health System,
to its Board of Directors. This appointment increases the size
of Colfax’s Board of Directors to eleven members.
Mitchell P. Rales, Chairman of the Board of Colfax, said, “We
are very pleased to have Phil join our Board. He has extensive
experience as a healthcare leader and has been integral to the
success of Penn Medicine’s hospital systems by spearheading key
strategic initiatives and recent expansion efforts. His addition to
the Board will further support Colfax in growing our medical
technology business. I am confident that his knowledge and
experience will assist the Board and the Colfax management team in
executing Colfax’s long-term growth plans.”
Mr. Okala has served as the Chief Operating Officer at the
University of Pennsylvania Health System since 2017. As Chief
Operating Officer, he has executive oversight for the health
system’s hospitals, clinical service line operations and
integration. Prior to his current role, Mr. Okala held various
positions with Penn Medicine since 2007, including serving as
Senior Vice President for Business Development from 2013 to 2017.
Before joining Penn Medicine, Mr. Okala held various positions with
other healthcare organizations including System Vice President of
the Cancer Service Line at Geisinger Health System, Vice President
for Clinical Strategic Planning at Roswell Park Cancer Institute
and management positions at the University of Texas MD Anderson
Cancer Center. Mr. Okala is an experienced hospital
executive who has led major health system initiatives for strategic
marketing positioning, overseen the expansion of clinical service
lines and facilitated the growth of the Penn Medicine health
system, including through successful mergers and strategic
alliances.
Mr. Okala holds a Bachelor of Science in Economics from the
University of Houston – University Park and a Master’s in Health
Service Administration from Texas Woman’s University. He is a
Fellow in the American College of Healthcare Executives (FACHE) and
currently serves on the boards of the Hospital and Healthsystem
Association of Pennsylvania, Holy Child School at Rosemont and
Vizient Mid-Atlantic Region.
ABOUT COLFAX CORPORATION
Colfax Corporation is a leading diversified technology company
that provides orthopedic and fabrication technology products and
services to customers around the world, principally under the DJO
and ESAB brands. Colfax believes that its brands are among the most
highly recognized in each of the markets that it serves. The
Company uses its Colfax Business System (“CBS”), a comprehensive
set of tools, processes and values, to create superior value for
customers, shareholders and associates. Colfax’s common stock is
traded on the NYSE under the ticker “CFX.”
Mike MacekVice President, FinanceColfax
Corporation+1-302-252-9129investorrelations@colfaxcorp.com
Colfax (NYSE:CFX)
Historical Stock Chart
From Apr 2024 to May 2024
Colfax (NYSE:CFX)
Historical Stock Chart
From May 2023 to May 2024